Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 569-575

  Iwatsuki, Masaaki ^a,b   Mimori, Koshi ^a   Sato, Tetsuya ^a   Toh, Hiroyuki ^a   Yokobori, Takehiko ^a   Tanaka, Fumiaki ^a   Ishikawa, Koichi ^a   Baba, Hideo ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

13q; cDNA microarray; CGH array; Colorectal cancer; SUGT1

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN; SUGT1 PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; SUGT1 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CANCER TISSUE; CELL CYCLE; CENTROMERE; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METAPHASE; PRIORITY JOURNAL; PROGNOSIS; BIOLOGICAL MODEL; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION PROFILING; LASER; METABOLISM; MICRODISSECTION; NUCLEIC ACID HYBRIDIZATION; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASERS; MICRODISSECTION; MODELS, GENETIC; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77149129272     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000531     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Verdecchia A, Francisci S, Brenner H, et al: Recent cancer survival in Europe: a 2000-02 period analysis of Eurocare-4 data. Lancet Oncol 8: 784-796, 2007.
3. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC and Lothe RA: The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45: 31-41, 2006.
4. He QJ, Zeng WF, Sham JS, et al: Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet Cytogenet 144: 112-118, 2003.
5. Kim MY, Yim SH, Kwon MS, et al: Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology 131: 1913-1924, 2006.
6. Lassmann S, Weis R, Makowiec F, et al: Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 85: 293-304, 2007.
7. Rooney PH, Boonsong A, McKay JA, et al: Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer 85: 1492-1498, 2001.
8. Tsafrir D, Bacolod M, Selvanayagam Z, et al: Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66: 2129-2137, 2006.
9. Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M and Mori M: Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. Int J Oncol 31: 333-338, 2007.
10. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006.
11. Yokoe T, Ohmachi T, Inoue H, et al: Clinical significance of growth differentiation factor 11 in colorectal cancer. Int J Oncol 31: 1097-1101, 2007.
12. Platzer P, Upender MB, Wilson K, et al: Silence of chromosomal amplifications in colon cancer. Cancer Res 62: 1134-1138, 2002.
13. Kitagawa K, Skowyra D, Elledge SJ, Harper JW and Hieter P: SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex. Mol Cell 4: 21-33, 1999.
14. Nishida K, Mine S, Utsunomiya T, et al: Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer Res 65: 401-409, 2005.
15. Quackenbush J: Microarray data normalization and transformation. Nat Genet 32 (Suppl.): S496-S501, 2002.
16. Brazma A, Hingamp P, Quackenbush J, et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371, 2001.
17. Venkatraman ES and Olshen AB: A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663, 2007.
18. Utsunomiya T, Hara Y, Kataoka A, et al: Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival. Clin Cancer Res 8: 2591-2594, 2002.
19. Utsunomiya T, Okamoto M, Hashimoto M, et al: A gene-expression signature can quantify the degree of hepatic fibrosis in the rat. J Hepatol 41: 399-406, 2004.
20. Ogawa K, Utsunomiya T, Mimori K, et al: Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893, 2005.
21. Niikura Y, Ohta S, Vandenbeldt KJ, Abdulle R, McEwen BF and Kitagawa K: 17-AAG, an Hsp90 inhibitor, causes kinetochore defects: a novel mechanism by which 17-AAG inhibits cell proliferation. Oncogene 25: 4133-4146, 2006.
22. Goetz MP, Toft D, Reid J, et al: Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol 23: 1078-1087, 2005.